Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.

Abstract

A non-myeloablative conditioning regimen was able to induce persistent remission in some patients with severe autoimmune diseases. There was no mortality or morbidity related to the procedure. The extent of remission does, however, remain to be established.